Selected research
Industry Growth & Trends
Global Psychoactive Substances Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Psychoactive Substances market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Psychoactive Substances is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Psychoactive Substances is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Psychoactive Substances is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Psychoactive Substances market include Alpha-CAT, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc., Cape Bouvard Technologies Pty Ltd, Cyrelian Pty Ltd., Enecta., GD Pharma, GW Pharmaceuticals PLC. and MedReleaf Australia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Psychoactive Substances market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Psychoactive Substances market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Psychoactive Substances market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Psychoactive Substances.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Psychoactive Substances market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Psychoactive Substances Market by Company
Alpha-CAT
AusCann Group Holdings Pty Ltd.
Cannabics Pharmaceuticals Inc.
Cape Bouvard Technologies Pty Ltd
Cyrelian Pty Ltd.
Enecta.
GD Pharma
GW Pharmaceuticals PLC.
MedReleaf Australia
Teewinot Life Sciences
Tilray
Zynerba Pharmaceuticals
Psychoactive Substances Segment by Type
Cannabinoids
Hallucinogens
Stimulants
Depressants
Psychoactive Substances Segment by Application
Neuropathic Disorders
Spasticity
Cancer
Psychoactive Substances Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychoactive Substances market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Psychoactive Substances and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychoactive Substances.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Psychoactive Substances companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cannabinoids
- Hallucinogens
- Stimulants
- Depressants
Applications
- Neuropathic Disorders
- Spasticity
- Cancer
Companies covered
- Alpha-CAT
- AusCann Group Holdings Pty Ltd.
- Cannabics Pharmaceuticals Inc.
- Cape Bouvard Technologies Pty Ltd
- Cyrelian Pty Ltd.
- Enecta.
- GD Pharma
- GW Pharmaceuticals PLC.
- MedReleaf Australia
- Teewinot Life Sciences
- Tilray
- Zynerba Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Psychoactive Substances Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Psychoactive Substances Market Size by Region (2021-2032)
- 1.4.1 Global Psychoactive Substances Market Size by Region (2021-2026)
- 1.4.2 Global Psychoactive Substances Market Size by Region (2027-2032)
- 1.5 Key Regions Psychoactive Substances Market Size (2021-2032)
- 1.5.1 North America Psychoactive Substances Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Psychoactive Substances Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Psychoactive Substances Market Size Growth Rate (2021-2032)
- 1.5.4 South America Psychoactive Substances Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Psychoactive Substances Market Size Growth Rate (2021-2032)
2 Psychoactive Substances Market by Type
- 2.1 Type Introduction
- 2.1.1 Cannabinoids
- 2.1.2 Hallucinogens
- 2.1.3 Stimulants
- 2.1.4 Depressants
- 2.2 Global Psychoactive Substances Market Size by Type
- 2.2.1 Global Psychoactive Substances Market Size Overview by Type (2021-2032)
- 2.2.2 Global Psychoactive Substances Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Psychoactive Substances Market Size Forecasted by Type (2027-2032)
- 2.3 Global Psychoactive Substances Market Size by Regions
- 2.3.1 North America Psychoactive Substances Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Psychoactive Substances Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Psychoactive Substances Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Psychoactive Substances Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Psychoactive Substances Market Size Breakdown by Type (2021-2026)
3 Psychoactive Substances Market by Application
- 3.1 Type Introduction
- 3.1.1 Neuropathic Disorders
- 3.1.2 Spasticity
- 3.1.3 Cancer
- 3.2 Global Psychoactive Substances Market Size by Application
- 3.2.1 Global Psychoactive Substances Market Size Overview by Application (2021-2032)
- 3.2.2 Global Psychoactive Substances Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Psychoactive Substances Market Size Forecasted by Application (2027-2032)
- 3.3 Global Psychoactive Substances Market Size by Regions
- 3.3.1 North America Psychoactive Substances Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Psychoactive Substances Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Psychoactive Substances Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Psychoactive Substances Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Psychoactive Substances Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Psychoactive Substances Industry Trends
- 4.2 Psychoactive Substances Industry Drivers
- 4.3 Psychoactive Substances Industry Opportunities and Challenges
- 4.4 Psychoactive Substances Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Psychoactive Substances Revenue (2021-2026)
- 5.2 Global Psychoactive Substances Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Psychoactive Substances Key Company Headquarters & Area Served
- 5.4 Global Psychoactive Substances Company, Product Type & Application
- 5.5 Global Psychoactive Substances Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Psychoactive Substances Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Psychoactive Substances Players Market Share by Revenue in 2025
- 5.6.3 2025 Psychoactive Substances Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Alpha-CAT
- 6.1.1 Alpha-CAT Company Information
- 6.1.2 Alpha-CAT Business Overview
- 6.1.3 Alpha-CAT Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Alpha-CAT Psychoactive Substances Product Portfolio
- 6.1.5 Alpha-CAT Recent Developments
- 6.2 AusCann Group Holdings Pty Ltd.
- 6.2.1 AusCann Group Holdings Pty Ltd. Company Information
- 6.2.2 AusCann Group Holdings Pty Ltd. Business Overview
- 6.2.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Portfolio
- 6.2.5 AusCann Group Holdings Pty Ltd. Recent Developments
- 6.3 Cannabics Pharmaceuticals Inc.
- 6.3.1 Cannabics Pharmaceuticals Inc. Company Information
- 6.3.2 Cannabics Pharmaceuticals Inc. Business Overview
- 6.3.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Portfolio
- 6.3.5 Cannabics Pharmaceuticals Inc. Recent Developments
- 6.4 Cape Bouvard Technologies Pty Ltd
- 6.4.1 Cape Bouvard Technologies Pty Ltd Company Information
- 6.4.2 Cape Bouvard Technologies Pty Ltd Business Overview
- 6.4.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Portfolio
- 6.4.5 Cape Bouvard Technologies Pty Ltd Recent Developments
- 6.5 Cyrelian Pty Ltd.
- 6.5.1 Cyrelian Pty Ltd. Company Information
- 6.5.2 Cyrelian Pty Ltd. Business Overview
- 6.5.3 Cyrelian Pty Ltd. Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Cyrelian Pty Ltd. Psychoactive Substances Product Portfolio
- 6.5.5 Cyrelian Pty Ltd. Recent Developments
- 6.6 Enecta.
- 6.6.1 Enecta. Company Information
- 6.6.2 Enecta. Business Overview
- 6.6.3 Enecta. Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Enecta. Psychoactive Substances Product Portfolio
- 6.6.5 Enecta. Recent Developments
- 6.7 GD Pharma
- 6.7.1 GD Pharma Company Information
- 6.7.2 GD Pharma Business Overview
- 6.7.3 GD Pharma Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GD Pharma Psychoactive Substances Product Portfolio
- 6.7.5 GD Pharma Recent Developments
- 6.8 GW Pharmaceuticals PLC.
- 6.8.1 GW Pharmaceuticals PLC. Company Information
- 6.8.2 GW Pharmaceuticals PLC. Business Overview
- 6.8.3 GW Pharmaceuticals PLC. Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GW Pharmaceuticals PLC. Psychoactive Substances Product Portfolio
- 6.8.5 GW Pharmaceuticals PLC. Recent Developments
- 6.9 MedReleaf Australia
- 6.9.1 MedReleaf Australia Company Information
- 6.9.2 MedReleaf Australia Business Overview
- 6.9.3 MedReleaf Australia Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MedReleaf Australia Psychoactive Substances Product Portfolio
- 6.9.5 MedReleaf Australia Recent Developments
- 6.10 Teewinot Life Sciences
- 6.10.1 Teewinot Life Sciences Company Information
- 6.10.2 Teewinot Life Sciences Business Overview
- 6.10.3 Teewinot Life Sciences Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Teewinot Life Sciences Psychoactive Substances Product Portfolio
- 6.10.5 Teewinot Life Sciences Recent Developments
- 6.11 Tilray
- 6.11.1 Tilray Company Information
- 6.11.2 Tilray Business Overview
- 6.11.3 Tilray Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Tilray Psychoactive Substances Product Portfolio
- 6.11.5 Tilray Recent Developments
- 6.12 Zynerba Pharmaceuticals
- 6.12.1 Zynerba Pharmaceuticals Company Information
- 6.12.2 Zynerba Pharmaceuticals Business Overview
- 6.12.3 Zynerba Pharmaceuticals Psychoactive Substances Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Zynerba Pharmaceuticals Psychoactive Substances Product Portfolio
- 6.12.5 Zynerba Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Psychoactive Substances Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Psychoactive Substances Market Size by Country (2021-2026)
- 7.3 North America Psychoactive Substances Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Psychoactive Substances Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Psychoactive Substances Market Size by Country (2021-2026)
- 8.3 Europe Psychoactive Substances Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Psychoactive Substances Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Psychoactive Substances Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Psychoactive Substances Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Psychoactive Substances Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Psychoactive Substances Market Size by Country (2021-2026)
- 10.3 South America Psychoactive Substances Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Psychoactive Substances Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Psychoactive Substances Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Psychoactive Substances Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst